Repros Therapeutics Inc (RPRX)

[corpstrat]

Thank you, Dew. I hope and believe you're being much too pessimistic, but it's likely still a buy even at 36%. (The uncertainty in my response is around the overall program: if chances of success of the main indications are dimmer still than 36%, then expected value may not be too hot.)